Connecting the dots !

EXPERTISE ATU /RTU (compassionate use)-Economic modelling-Real life studies

Statistical methology, health economics, market access

Immunotherapeutics, medical devices, rare diseases

Clinical trials, epidemiology, US operations with strategic partner

FDA CDISC & ICH GCP compliant, R&D taxes reduction

News

10/04/13 - Statitec selected to conduct PhagoBurn clinical trial

STATITEC the...

05/23/13 - What is the “wake up juice” for biotech capitalization?

As current global growth is difficult to capture, countries are trying to focus on...

07/02/12 - NEJM Myeloma Phase III publication

May 2012 New England Journal of Medicine published results from a phase...

03/16/12 - Gearing up life sciences innovation to today's economic twist

This Statitec perspective paper is aiming at...

Vidéo

Video Presentation